Re: Notice of exempt distribution
|
5
|
Zenith Epigenetics
|
Jul 28, 2020 01:01PM
|
Re: Name Confusion
|
1
|
Zenith Epigenetics
|
Jul 26, 2020 09:29PM
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
5
|
Zenith Epigenetics
|
Jul 16, 2020 04:45PM
|
Re: Prospects for resverlogix
|
10
|
Resverlogix Corp.
|
Jul 15, 2020 11:47AM
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:43PM
|
Re: Restricted Share Units - approx. 5 million
|
3
|
Resverlogix Corp.
|
Jul 07, 2020 02:39PM
|
Re: Restricted Share Units - approx. 5 million
|
7
|
Resverlogix Corp.
|
Jul 07, 2020 11:39AM
|
Re: Report of exempt distribution
|
1
|
Resverlogix Corp.
|
Jul 01, 2020 02:40PM
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
6
|
Resverlogix Corp.
|
Jun 22, 2020 12:26PM
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
7
|
Resverlogix Corp.
|
Jun 22, 2020 12:14PM
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 10:52AM
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 12:24AM
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 12:04AM
|
Re: Zenith a Loser Too
|
5
|
Resverlogix Corp.
|
Jun 16, 2020 05:56PM
|
Re: Zenith A Loser Too
|
1
|
Zenith Epigenetics
|
Jun 16, 2020 03:33PM
|
Zenith A Loser Too
|
2
|
Zenith Epigenetics
|
Jun 16, 2020 01:38PM
|
Re: Zenith a Loser Too
|
7
|
Resverlogix Corp.
|
Jun 16, 2020 01:02PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
2
|
Resverlogix Corp.
|
Jun 13, 2020 03:53PM
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
3
|
Resverlogix Corp.
|
Jun 13, 2020 10:43AM
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
8
|
Resverlogix Corp.
|
Jun 12, 2020 04:31PM
|